17.78EUR+3.13%Mkt Cap: 203.73M EURP/E: —Last update: 2026-05-14
Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures auto…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)8.60
PEG0.98
P/B0.85
P/S0.81
EV/EBITDA11.39
EV/Revenue1.29
EPS (TTM)-0.28
EPS (Forward)1.95
Cash Flow & Leverage
FCF Yield-9.88%
FCF Margin-8.02%
Operating CF-433.00K EUR
CapEx (TTM)16.23M EUR
Net Debt/EBITDA3.85
Net Debt109.08M EUR
Technical
SMA 5018.19 (-2.3%)
SMA 20022.63 (-21.4%)
Beta0.80
S&P 52W Chg24.23%
Avg Vol (30d)11.16K
Avg Vol (10d)15.04K
Technical Indicators
RSI (14)48.4
MACD-0.3198
MACD Signal-0.3189
MACD Hist.-0.0009
BB Upper19.99 EUR
BB Middle18.07 EUR
BB Lower16.15 EUR
BB Width21.25%
ATR (14)0.9182 EUR
Vol Ratio (20d)0.89x
52W Range
16.349% of range33.10
52W High33.10 EUR
52W Low16.34 EUR
Profitability
Gross Margin25.60%
EBITDA Margin11.31%
Profit Margin-0.10%
Oper. Margin10.33%
ROE-0.10%
ROA-0.06%
Revenue Growth-11.10%
Earnings Growth—
Balance Sheet
Debt/Equity0.56
Current Ratio3.97
Quick Ratio1.79
Book Value/Sh19.75 EUR
Cash/Share1.897 EUR
Dividends
Fwd Div Rate0.6000 EUR
Trail. Div Rate0.0000 EUR
Div. Yield3.39%
5Y Avg Yield1.65%
Payout Ratio47.24%
Ex-Div DateJun 24, 2026
Pay Date—
Splits
Last Split2.994:1
Split DateJul 31, 2006
Ownership
Shares Out.12.16M
Float6.63M
Insiders50.61%
Institutions38.32%
Analyst Consensus
Rating1.7 (Buy)
Target (Mean)26.00 EUR
Target Range20.00 EUR – 37.00 EUR
# Analysts5
Company
Market Cap203.73M EUR
Enterprise Value323.02M EUR
Revenue (TTM)250.86M EUR
Gross Profit64.22M EUR
Net Income (TTM)-242.00K EUR
Revenue/Share20.64 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees1.3K
Last Price17.78 EUR
CountryDE
SectorHealthcare
IndustryMedical Devices
ISIN—